PROPANC BIOPHARMA, INC.
302, 6 Butler Street
Camberwell, VIC, 3124 Australia
October 26, 2018
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549
|Re:||Propanc Biopharma, Inc.|
|Registration Statement on Form S-1|
|File No. 333-227877|
Ladies and Gentleman:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Propanc Biopharma, Inc. (the “Company”) hereby requests that the effective date of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) be accelerated so that it will become effective at 10:00 A.M. Eastern Time on Tuesday, October 30, 2018, or as soon as practicable thereafter.
We request that we be notified of such effectiveness by a telephone call to Jonathan Shechter of Foley Shechter LLP at (212) 335-0465, or in his absence Sasha Ablovatskiy of Foley Shechter LLP at (212) 335-0466. We also respectfully request that a copy of the written order from the Securities and Exchange Commission verifying the effective time and date of such Registration Statement be sent to Foley Shechter LLP, attention: Jonathan Shechter, via facsimile at (917) 688-4092.
|PROPANC BIOPHARMA, INC.|
|By:||/s/ James Nathanielsz|
|Title:||Chief Executive Officer and Chief Financial Officer|
|Cc:||Jonathan Shechter, Foley Shechter LLP|
|Sasha Ablovatskiy, Foley Shechter LLP|